Related Experiment Videos
Therapeutic apheresis application using membrane plasma fractionation technology: present scope and limitations
1R & D Department, Kawasumi Laboratories, Inc., Tokyo, Japan. asueoka@kawasumi.co.jp
Summary
Membrane plasma fractionation uses microporous filters for therapeutic apheresis. This technology, applied in double filtration plasmapheresis (DFPP), aids in treating various diseases by separating plasma components.
Area of Science:
- Biomedical Engineering
- Materials Science
- Medical Technology
Background:
- Membrane technologies are integral to therapeutic apheresis procedures like plasma separation and fractionation.
- Microporous membranes with pore sizes between 0.01-0.04 micrometers are specifically used for plasma fractionation.
- Membrane plasma fractionators are a key component in the double filtration plasmapheresis (DFPP) system.
Purpose of the Study:
- To summarize the current applications and limitations of membrane plasma fractionation.
- To provide an overview of the scope of membrane plasma fractionation in medical treatments.
- To highlight the role of membrane technology in therapeutic apheresis.
Main Methods:
- Review of existing literature and applications of membrane plasma fractionation.
- Analysis of the characteristics of microporous membranes used in plasma separation.
- Examination of the integration of membrane plasma fractionators within the double filtration plasmapheresis (DFPP) system.
Main Results:
- Membrane plasma fractionation is effectively used as a secondary filter in DFPP systems.
- The technology is applied in the treatment of a diverse range of diseases.
- The microporous structure of the membranes is crucial for efficient plasma component separation.
Conclusions:
- Membrane plasma fractionation is a valuable tool in therapeutic apheresis.
- Understanding the scope and limitations is essential for optimizing its clinical use.
- Further research may enhance the efficacy and expand the applications of this technology.